These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 18972439)

  • 21. [Anatomical and functional plasticity of pancreatic beta-cells and type 2 diabetes].
    Cerasi E; Ktorza A
    Med Sci (Paris); 2007 Oct; 23(10):885-94. PubMed ID: 17937902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
    Marchesini G; Brizi M; Bianchi G; Tomassetti S; Bugianesi E; Lenzi M; McCullough AJ; Natale S; Forlani G; Melchionda N
    Diabetes; 2001 Aug; 50(8):1844-50. PubMed ID: 11473047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes.
    Petit JM; Guiu B; Duvillard L; Jooste V; Brindisi MC; Athias A; Bouillet B; Habchi M; Cottet V; Gambert P; Hillon P; Cercueil JP; Verges B
    Clin Nutr; 2012 Aug; 31(4):520-5. PubMed ID: 22209679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease.
    Simopoulos AP
    Nutrients; 2013 Jul; 5(8):2901-23. PubMed ID: 23896654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Obesity--pacemaker of the metabolic syndrome].
    Knappe G
    Z Arztl Fortbild (Jena); 1992 Sep; 86(18):891-4. PubMed ID: 1413907
    [No Abstract]   [Full Text] [Related]  

  • 26. Childhood obesity and the metabolic syndrome.
    Chia DJ; Boston BA
    Adv Pediatr; 2006; 53():23-53. PubMed ID: 17089862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic Profiles of Adipose and Liver Tissues from an Animal Model of Metabolic Syndrome Fed Purple Vegetables.
    Ayoub HM; McDonald MR; Sullivan JA; Tsao R; Meckling KA
    Nutrients; 2018 Apr; 10(4):. PubMed ID: 29642414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [NASH in children].
    Ida S; Yoshimura N
    Nihon Rinsho; 2006 Jun; 64(6):1168-72. PubMed ID: 16768127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic syndrome: definition, pathophysiology, and mechanisms.
    Miranda PJ; DeFronzo RA; Califf RM; Guyton JR
    Am Heart J; 2005 Jan; 149(1):33-45. PubMed ID: 15660032
    [No Abstract]   [Full Text] [Related]  

  • 30. Raised hepatic free fatty acids in a patient with acute fatty liver after gastric surgery for morbid obesity.
    Cairns SR; Kark AE; Peters TJ
    J Clin Pathol; 1986 Jun; 39(6):647-9. PubMed ID: 3722418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Glitazones and the metabolic syndrome: mechanism of action, pathophysiology and therapeutic indications].
    Gomes MB
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):271-80. PubMed ID: 16767293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinol-binding protein 4 and new adipocytokines in nonalcoholic fatty liver disease.
    Tönjes A; Blüher M; Stumvoll M
    Curr Pharm Des; 2010 Jun; 16(17):1921-8. PubMed ID: 20370670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Vasculature in Prediabetes.
    Wasserman DH; Wang TJ; Brown NJ
    Circ Res; 2018 Apr; 122(8):1135-1150. PubMed ID: 29650631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obstructive sleep apnea and dyslipidemia: importance of the liver axis.
    Mirrakhimov AE; Mirrakhimov EM
    Sleep Breath; 2013 May; 17(2):443-4. PubMed ID: 23070526
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pathophysiology of NASH].
    Takei Y; Ikejima K; Sato N
    Nihon Shokakibyo Gakkai Zasshi; 2004 Nov; 101(11):1194-203. PubMed ID: 15570867
    [No Abstract]   [Full Text] [Related]  

  • 36. Update on nonalcoholic fatty liver disease.
    McCullough AJ
    J Clin Gastroenterol; 2002 Mar; 34(3):255-62. PubMed ID: 11873108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ghrelin and liver disease.
    Quiñones M; Fernø J; Al-Massadi O
    Rev Endocr Metab Disord; 2020 Mar; 21(1):45-56. PubMed ID: 31758299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Patomechanisms of hepatic steatosis].
    Fülöp P; Paragh G
    Orv Hetil; 2010 Feb; 151(9):323-9. PubMed ID: 20159747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease.
    Tarantino G; Caputi A
    World J Gastroenterol; 2011 Sep; 17(33):3785-94. PubMed ID: 21987620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation.
    Ndumele CE; Nasir K; Conceiçao RD; Carvalho JA; Blumenthal RS; Santos RD
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1927-32. PubMed ID: 21546603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.